KLRK1 and prostate neoplasm: To address the discrepancies between these study findings, we used three different syngeneic tumor models, the melanoma B16F10, the prostate tumor TRAMP-C2 (TC2), and the lung carcinoma LLC1, to compare tumor incidence between tumor cells engineered to overexpress the soluble human NKG2D ligand sMICB and the parental tumor cell lines.